Financials

News Ideas Technicals

PVCT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Provectus Biopharmaceuticals, Inc.

Total assets of PVCT for Q4 23 is 1.45 M USD, 14.27% less than the previous Q3 23. And total liabilities decreased by 1.81% in Q4 23 to 9.04 M USD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—